TransPacific Venture Partners (TPV) is an Asia-based venture capital firm that actively assesses and invests in early-stage medical technology ventures. The firm focuses on investing in promising companies across the biopharmaceutical spectrum, particularly at late stages of clinical development, and emphasizes novel therapeutics in major disease areas.
Focus Areas
Investment Types
Notable Investments
